Dubai Health Authority, United Arab Emirates.
Diabetes Res Clin Pract. 2021 Mar;173:108678. doi: 10.1016/j.diabres.2021.108678. Epub 2021 Jan 28.
Physiological impact of the intermittent or prolonged fasting is known from various studies on healthy subjects. However, data on impact of fasting on biochemical and biometric parameters in people with diabetes is building up. Safety of Ramadan fasting has always been assessed after Ramadan. This study looked into the immediate effect of fasting during the fasting days compared to time before and after the fasting month.
This is an observational study. We looked into people with biometric and biochemical records before Ramadan, and we followed them up during and after Ramadan prospectively. We were aiming for assessing the biochemical and biometric changes for people with diabetes during Ramadan in comparison to pre-and post Ramadan. As well as the differences between these measures according to type and treatment of diabetes in those who fasted as well as in those who did not fast during Ramadan.
Total of 342 patients were recruited to the study. All were patients with diabetes at a mild to moderate risk of complications if fasted. Majority were males 52.3% (n = 180), while females were 47.7% (n = 162). Most of the results showed a U shape between Pre-Ramadan, During Ramadan and Post-Ramadan periods. there was a modest but significant reduction in weight but regained after Ramadan.
Our study suggests that for many people with diabetes fasting is not associated with an increased risk to their glycemic control, their weight and/or their blood pressure. Indeed, what is seen is marginal benefit or no change in all parameters. This stratifies the ongoing recommendation that allows patients with categorized as low risk to fast Ramadan or non-Ramadan days whenever desired.
间歇性或长期禁食对健康受试者的生理影响已在各种研究中得到证实。然而,关于禁食对糖尿病患者生化和生物计量参数影响的数据正在不断增加。斋月禁食的安全性一直是在斋月后进行评估的。本研究旨在观察与斋月前和斋月后相比,禁食日期间禁食对生化和生物计量参数的即时影响。
这是一项观察性研究。我们观察了斋月前有生物计量和生化记录的人,并前瞻性地对他们进行了随访。我们的目的是评估糖尿病患者在斋月期间的生化和生物计量变化,并与斋月前和斋月后进行比较。以及在斋月期间禁食和不禁食的糖尿病患者中,根据糖尿病的类型和治疗方法,这些措施之间的差异。
共有 342 名患者被纳入研究。所有患者都有糖尿病,在轻度到中度并发症风险下可以禁食。大多数是男性,占 52.3%(n=180),而女性占 47.7%(n=162)。大多数结果显示,在斋月前、斋月中和斋月后期间呈 U 形。体重略有但显著下降,但在斋月后恢复。
我们的研究表明,对于许多糖尿病患者来说,禁食不会增加血糖控制、体重和/或血压的风险。事实上,所有参数都显示出边缘获益或没有变化。这对正在进行的建议进行了分层,允许低风险的患者在斋月或非斋月期间根据需要禁食。